noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

NGA - National Governors Association

NGA HHS Institute 2025: Making Innovative Tech Work for Health & Human[...]
Washington State Department of[...]

State ferries to pay tribute to veterans with flags, whistle salute on[...]
GeorgiaTech - Georgia Institute of[...]

New Composter to Enhance Campus Waste Reduction

Healthcare

AIM ImmunoTech Inc.

11/10/2025 | Press release | Distributed by Public on 11/10/2025 08:00

AIM ImmunoTech Details New UPMC Abstract on Completed Clinical Trial Involving Ampligen's Synergistic Potential in the Treatment of Advanced Recurrent Ovarian Cancer

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

AIM ImmunoTech Inc. published this content on November 10, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 10, 2025 at 14:00 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]